PERITONEAL DIALYSIS INTERNATIONAL, cilt.21, sa.5, ss.448-454, 2001 (SCI-Expanded)
Objective: Gonadal dysfunction has been recognized for a long time in uremic male patients. The present study assesses the hypothalamo-pituitary-testicular axis and growth hormone status in male continuous ambulatory peritoneal dialysis (CAPD) patients, before and after recombinant human erythropoietin (rHuEPO) therapy.